信德(00242.HK)與香港中旅為合營信德中旅提供財務資助
信德集團(00242.HK)公布,與香港中旅合營公司信德中旅於今日(15日)訂立續訂融資協議,中信銀行授出4億元循環貸款融資,為期一年,年利率為香港銀行同業拆息加1%,用於為中信銀行提供的現有融資進行再融資。
信德集團與香港中旅個別作為擔保人,將為信德中旅提供續訂公司擔保,金額最多為授予信德中旅的續訂融資本金額的50%、即2億元,另加相關利息及其他費用。
集團表示,隨著香港、澳門和中國內地之間的邊境重新開放,信德中旅的服務自去年初起已逐步恢復,認為在信德中旅繼續恢復載客量至疫情前水平的同時,續訂融資將提供的流動資金對於其維持日常營運的現金流至關重要。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.